All News

Feb. 11 India's Zydus, US unit settle Mirabegron patent dispute with $120 million payment RE
Feb. 11 Zydus Lifesciences enters settlement agreement with Astellas over Myrbetriq RE
Feb. 11 Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,100 From INR1,130, Keeps at Buy MT
Feb. 10 Zydus Lifesciences : Press Release 10-02-2026 NewspaperPublication10022026 PU
Feb. 10 Zydus Lifesciences Limited, Q3 2026 Earnings Call, Feb 10, 2026
Feb. 09 India's Aurobindo Pharma posts higher profit on steady domestic demand RE
Feb. 09 India's Stocks Rise on Monday as Trade Deal Clarity Boosts Investor Appetite MT
Feb. 09 Zydus Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
Feb. 09 Zydus Lifesciences' Net Profit Rises in Fiscal Q3; Shares Up 4% MT
Feb. 09 India's Zydus Life posts surprise profit rise on strong North American sales RE
Feb. 09 Zydus Lifesciences Q3 consol net profit 10.42 billion rupees RE
Feb. 08 Diary - India economic, corporate events on February 9 RE
Feb. 06 Essential Medicines & Injunctions – Delhi High Court's Landmark Balancing Act AQ
Feb. 05 Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes RE
Feb. 04 Zydus Lifesciences receives tentative approval from USFDA for dapagliflozin tablets RE
Feb. 04 Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Dapagliflozin Tablets, 5 Mg and 10 Mg CI
Jan. 23 Indian Companies Receive Approval for Generic Versions of Wegovy and Ozempic FW
Jan. 23 Zydus Lifesciences says USFDA inspection closed with 2 observations for Ankleshwar unit-2 plant RE
Jan. 22 Indian drugmakers get regulatory nod to sell generic Wegovy, heating obesity-drug race RE
Jan. 22 Zydus Lifesciences Launches Nivolumab Biosimilar in India MT
Jan. 21 Zydus Lifesciences launches biosimilar of Nivolumab in India RE
Jan. 21 Zydus Lifesciences Limited Launches Biosimilar of Nivolumab, Tishtha CI
Jan. 20 Zydus Lifesciences Reportedly Eyes Acquisition of Ardelyx for $2.5 Billion CI
Jan. 15 Agenus Falls After $141 Million Zydus Deal Closes DJ
Jan. 15 Agenus Announces Closing of $141 Million Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness CI
No results for this search
  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. News Zydus Lifesciences Limited